Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

Recruiting now · Not applicable

Conditions studied: Myopia

In brief

To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment

Key facts

Study ID: NCT07160036
Run by: Ruihua Wei
People needed: 180
Starts: 2025-09-20
Expected to finish: 2025-12-20
Last updated by the study team: 2025-09-15

Who can join

Age: 6 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

6 - 55 years old, gender not limited; Obtained informed consent.

You may not qualify if…

Children with obvious strabismus and amblyopia
With congenital eye disease, such as congenital cataract, congenital retinal disease
Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
Bnormal intraocular pressure and clinical significance (IOP <10 mmHg or IOP>21mmHg or binocular IOP difference ≥5mmHg)
Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
Optic nerve damage or congenital optic nerve dysfunction
Can not be regularly checked
The adjustment range is less than 8D or obvious near difficulties
Other reasons researchers think it is not suitable for inclusion in researchers

Where it is running

Tianjin Medical University Eye Hospital — Tianjin, Tianjin Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.